Extensions

To determine the patent term adjustments (PTA), patent term extensions (PTE), continuation applications, divisional applications, related family members, and projected expiration date for US Patent 11069337, information from the USPTO's Patent Public Search is required. As an AI, I don't have direct, real-time access to the USPTO's live database to perform this search and extract precise details on PTA/PTE or to construct a complete family tree. However, I can explain how this information is generally determined and what to look for when accessing such a database.

Based on the information provided in the patent text itself and general patent law:

• Filing Date: March 4, 2019
• Issue Date: July 20, 2021
• Priority Date: March 6, 2018 (Japanese Application No. 2018-039754)

General Principles for Patent Term and Adjustments:

• Base Patent Term: For applications filed on or after June 8, 1995, the term of a U.S. utility patent is generally 20 years from its earliest effective non-provisional filing date.
• Patent Term Adjustment (PTA): This compensates for certain delays by the USPTO during patent prosecution. It is added to the 20-year term. Factors that can lead to PTA include delays in issuing an Office Action, delays in issuing a patent after payment of the issue fee, and delays causing the patent to issue more than three years from its filing date.
• Patent Term Extension (PTE): This is less common and typically applies to patents covering certain pharmaceutical products to compensate for regulatory review periods, such as by the FDA. There is no indication in the patent information provided that US11069337 would be eligible for PTE.
• Continuations, Divisionals, and Continuations-in-Part: These are types of continuing applications that claim priority to an earlier "parent" application. They generally benefit from the filing date of the earliest application for which a benefit is claimed.
  • Continuation applications pursue different claims but share the same disclosure as the parent.
  • Divisional applications are filed when an examiner issues a restriction requirement, meaning there are multiple inventions disclosed in the parent application.
  • Continuation-in-part (CIP) applications allow for the addition of new subject matter. However, only claims fully supported by the original parent disclosure benefit from that earlier date.
• Terminal Disclaimer: A terminal disclaimer can shorten the life of a patent, typically filed to overcome a non-statutory double patenting rejection, causing the patent to expire on the same date as an earlier issued patent.

Analysis for US 11069337:

1. Patent Term Adjustments (PTA): The Google Patents information states the legal status as "Active, expires 2039-06-20". The calculated expiration date based on the filing date (March 4, 2019) plus 20 years would be March 4, 2039. The fact that the stated expiration is June 20, 2039, suggests there has been a PTA of approximately 3 months and 16 days. To get the precise PTA calculation, one would need to access the "Patent Center Portal" (formerly Public PAIR) on the USPTO website and look for the PTA calculation.

2. Patent Term Extensions (PTE): There is no information in the provided patent text or associated snippets to suggest that US11069337 has received or is eligible for Patent Term Extension under 35 U.S.C. § 156. Such extensions are primarily for pharmaceuticals.

3. Continuation, Divisional, and Related Family Members:

   • The patent claims priority from Japanese Application No. 2018-039754, filed on Mar. 6, 2018. This is a foreign priority claim, not a domestic continuation or divisional.
   • The Google Patents page lists "Other versions: US20190279611A1 (en)". This indicates that US11069337B2 is a granted patent that stemmed from US20190279611A1, which is a U.S. patent application publication. This is the published application that led to the granted patent.
   • To definitively identify any domestic continuation or divisional applications, one would need to perform a full family search on the USPTO database (e.g., using Patent Public Search). These are usually listed under the "Continuity Data" section in the patent's record. Without direct access to the USPTO database, I cannot confirm if any such applications exist for US11069337.

4. Projected Expiration Date: Based on the information from Google Patents, the adjusted expiration date for US11069337 is June 20, 2039. This date already incorporates any Patent Term Adjustments. [cite: Google Patents]